No abstract available.
Aspirin ; Diverticulitis ; Hemorrhage

No abstract available.
Aspirin* ; beta Catenin*

No abstract available.
Aspirin* ; Epithelial Cells*

No abstract available.
Aspirin ; Dialysis ; Humans

33 patients who were definitely diagnosed with acute myocardial infarction (MI) using WHO criteria were involved in this study. Statistic method of STARTA 95 was used to compare erythrocyte aggregation after and before using aspirin. Aggregation of erythrocyte increased in the acute stage of MI. Oral aspirin with dose of 0.1g per day for 3 days reduced significantly the erythrocyte aggregation in MI patients, compared with baseline.
Aspirin ; Erythrocyte Aggregation

Announcement of some initial results of making and investigating some particularizes of aspirin microfollicle. Percentage of asprin between theory and reality has remarkable change (+16.57 to -1.37). In generally, the microcapsules sample have low rate of Asp/EC, the aspirin microencapsulated rate is high and vice versa. Parameters of asparin percentage, rate of Asp/EC influence on asparin microencapsulated rate. Asparin capsule with EC box can be made with relatively high microencapsulated rate productivity. Aspirin capsule can last liberation of pharmaceutical material and give long-lasting effect in systems
Aspirin ; Pharmaceutical Preparations

No abstract available.
Aspirin ; Colorectal Neoplasms ; Humans

OBJECTIVETo examine the association between long-term oral low-dose aspirin and overall survival in colorectal cancer patients after diagnosis.

METHODSThe literature databases, such as PubMed, Embase, Cochrane Library, Web of Science, CBM, CNKI, and Wanfang database, were extensively searched to retrieve the comparative studies about the association between low-dose aspirin use after colorectal cancer diagnosis and overall survival published before June 2014. The state 12.0 version software was used for meta-analysis. The quality of these studies was assessed using the Newcastle-Ottawa scale.

RESULTSThere were eight studies meeting the inclusion criteria for meta-analysis. The total sample size of these studies included 28 103 cases and the score of all the studies was more than 6 points. Meta-analysis of the data using I(2) test showed significant heterogeneity (I(2)=78.2%, P<0.01), therefore, a random effect model was performed. Aspirin use after diagnosis was associated with longer overall survival (HR=0.732, 95% CI:0.613-0.875, P<0.01). There were seven studies with the same design or tumor stage in I-IIII period respectively for sensitivity analysis. The results of studies showed that the sensitivity was low and accurate (HR=0.687, 95% CI: 0.557-0.849, P<0.01; HR=0.682, 95% CI: 0.539-0.864, P<0.01).

CONCLUSIONMeta-analysis shows that long-term oral low-dose aspirin after diagnosis of colorectal cancer is identified as a significant prognostic factor.

No abstract available.
Aspirin ; Humans ; Prevalence

No abstract available.
Aspirin ; Humans ; Myocardial Infarction